{"name":"Vaxine Pty Ltd","slug":"vaxine-pty-ltd","ticker":"","exchange":"","domain":"vaxine.net","description":"","hq":"Bedford Park","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"HBsAg","genericName":"HBsAg","slug":"hbsag","indication":"Prevention of hepatitis B virus infection in unvaccinated or non-immune individuals","status":"marketed"},{"name":"Commercial Hepatitis B vaccine","genericName":"Commercial Hepatitis B vaccine","slug":"commercial-hepatitis-b-vaccine","indication":"Prevention of hepatitis B virus infection in unvaccinated or non-immune populations","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Radvax","genericName":"Radvax","slug":"radvax","indication":"Other","status":"phase_1"},{"name":"Recombinant influenza hemagglutinin","genericName":"Recombinant influenza hemagglutinin","slug":"recombinant-influenza-hemagglutinin","indication":"Influenza prevention","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"SpikoGen vaccine","genericName":"SpikoGen vaccine","slug":"spikogen-vaccine","indication":"COVID-19 prevention (SARS-CoV-2 infection)","status":"phase_3"}]}],"pipeline":[{"name":"HBsAg","genericName":"HBsAg","slug":"hbsag","phase":"marketed","mechanism":"HBsAg is a hepatitis B surface antigen used as an immunogen to stimulate the body's immune system to produce protective antibodies against hepatitis B virus infection.","indications":["Prevention of hepatitis B virus infection in unvaccinated or non-immune individuals"],"catalyst":""},{"name":"Commercial Hepatitis B vaccine","genericName":"Commercial Hepatitis B vaccine","slug":"commercial-hepatitis-b-vaccine","phase":"phase_3","mechanism":"A hepatitis B vaccine that stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen, providing protection against HBV infection.","indications":["Prevention of hepatitis B virus infection in unvaccinated or non-immune populations","Post-exposure prophylaxis in hepatitis B-exposed individuals"],"catalyst":""},{"name":"Radvax","genericName":"Radvax","slug":"radvax","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Recombinant influenza hemagglutinin","genericName":"Recombinant influenza hemagglutinin","slug":"recombinant-influenza-hemagglutinin","phase":"marketed","mechanism":"Recombinant influenza hemagglutinin stimulates the immune system to produce antibodies and cellular immunity against influenza virus.","indications":["Influenza prevention"],"catalyst":""},{"name":"SpikoGen vaccine","genericName":"SpikoGen vaccine","slug":"spikogen-vaccine","phase":"phase_3","mechanism":"SpikoGen is a recombinant protein vaccine designed to stimulate immune responses against SARS-CoV-2 spike protein.","indications":["COVID-19 prevention (SARS-CoV-2 infection)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-01-31","type":"deal","source":"simplywall.st","summary":"Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders - simplywall.st","headline":"Sanofi Buyout Of Dynavax Recasts Adult Vaccine Growth For Shareholders","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-08","type":"deal","source":"The Australian","summary":"$1bn CSL deal ‘lacked value for money’ proof - The Australian","headline":"$1bn CSL deal ‘lacked value for money’ proof","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOakxYRDk4M1BERXhYSUNxX29OVnh0NHZnZ0FXWTVYd2MxdmZsRHl2V2oyMWtCUEFpNVl2enBNTlhtSXUtWS1zTUJVWloyVWdqRzlzNUtNY2ZTVzFuZHU1aDNtSDZPcTE5RGFiNEl6RE55NmpKdmhEcVlzdFYxZ1JvcGhPX2V0MWlqZzBDZVp3VmZWVjJFMHNaYmVUY3M?oc=5","date":"2025-10-13","type":"pipeline","source":"Meyka","summary":"Typhoid Vaccine News Today: Pharma Stocks Surge Amid U.S. CDC Advisory - Meyka","headline":"Typhoid Vaccine News Today: Pharma Stocks Surge Amid U.S. CDC Advisory","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-03-05","type":"regulatory","source":"Medical Dialogues","summary":"Aurobindo Pharma arm terminates agreement with Hilleman Labs Singapore for pentavalent vaccine - Medical Dialogues","headline":"Aurobindo Pharma arm terminates agreement with Hilleman Labs Singapore for pentavalent vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOR0czZzRJTUlnck9hSTdzejJhdG1pMkJnT29XVFhBYkJTY204d1pjME01bFFrUVdBTTR6ZXgzV09SWHpKb1lvOUVVbldzdVJFVGNBX0lUYWw0WWVBcFJIWmVPZzdCbDFFTl9hYm56MlAwRnVaT19wWmVxLTlMYVBhalpjRGdkYnE1M1oyeTdmbkRWWDVlOG9VbFB5aU15UVZEVUJEZmtsTk9sLXFtRm44U1FkbnN0Z2VZU1ZxaU15WFFvdnRuZkd0dDljMnN3MEE?oc=5","date":"2024-11-18","type":"pipeline","source":"BioSpectrum Asia","summary":"Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan - BioSpectrum Asia","headline":"Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-02-19","type":"pipeline","source":"businesswire.com","summary":"The Pharmaceutical Industry in South Africa 2023 - Profiles of 120+ Companies Including Aspen Pharmacare, Adcock Ingram, Bayer, GlaxoSmithKline, Pfizer, Clicks, Dis-Chem & Nativa - ResearchAndMarkets.","headline":"The Pharmaceutical Industry in South Africa 2023 - Profiles of 120+ Companies Including Aspen Pharmacare, Adcock Ingram,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1wYWlyaTJNNjB3UGxyRkxkMmtNUjAwS2NFMFR0UU5RejFxS0ViSzROQS1RWVV1d01aRDk2NFkydUNpZFhHQTJWaDJwVjNjUnFmdmc4aFd3aXBicFRvWjFaV2d3RjJmTHNVM3VaanZLNF9CZ0ZWSnA4?oc=5","date":"2023-06-01","type":"pipeline","source":"Global Biotechnology Company","summary":"Global Biotechnology Company - Global Biotechnology Company","headline":"Global Biotechnology Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPVmJtcU55N2QtUFpLUkpPakFPYlV4S2d4c1Y2bE5Kb2JiNUFqanI5X2wxa2R5TnRMb1d3T1BTNFdQNG8tcFRzWkhXaUVpYy1JVFpOVU51blBXMkhzeVJCeG1BbGJUeGxZTHBvQXdGUmNUVGl3TktiMWY3U0gwcjhOeTRYRjRHSUI3QkdjTkd1aWFCRFNsVEV3aw?oc=5","date":"2021-07-06","type":"pipeline","source":"Grand View Research","summary":"COVID-19 Vaccine Development Tools Market Report, 2028 - Grand View Research","headline":"COVID-19 Vaccine Development Tools Market Report, 2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQSVJxUWQ1WjJKLWpIUzY3b3pzaVZyc19uTHBFYTNwczkzNmo2MmQ5a0xkLWlxbGduR0o0aFJ4ZXRmUkR0bkduUEhLaWFjRDZaM2hTbmtDaVNWU3dJXzFtaml3aEpsNkl3d0RINU01dmNzaHhxc1FvMmJvaF9OWlU1VUJnMHpHZ0FENF9RRnhWUzBJNkdsdGNqT3I3ZHIxS1poUGNnTUpZcEpjX0ZUNnlJRU02MUlpOENyZG9UTUlYNEI5dw?oc=5","date":"2021-02-18","type":"pipeline","source":"AFR","summary":"Why the three biggest vaccine makers failed on COVID-19 - AFR","headline":"Why the three biggest vaccine makers failed on COVID-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNSGx0b2l2Sl81dTRGN3lzeGJMT3hnUFdxaTZEZ2lvNVFYaElkVXB6anRqRXZaRGJXem9jbVE3SXFTOHc0aV9SMzFNblBOVHhhZHZFbllOc2JEbnNCcmZHMGE0V05UMmp2RktrRWFRNDB5RDU0N1Q5NV92b2JmY2ZnTE83SUpBUQ?oc=5","date":"2020-05-26","type":"deal","source":"Pharmaceutical Technology","summary":"Vaxine and Medytox partner on Covid-19 vaccine development - Pharmaceutical Technology","headline":"Vaxine and Medytox partner on Covid-19 vaccine development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQajMxT1g5UWtQQW5LUExaY1FHQ3FOVXpkTnlHbC1PNVpRUXRjbHRYM0pxQjVVa2ZobzN4QmROTENIM3IzaVEta0ViY19uWERCVmd6ZGlveWhtbHFvWThiZjNLUFFMWWVJbVdBb3NxSnc0cHJHd3BIa0VGWUFNTi1lck1QRllETElYLVZpZUlfalo3SFVDVXc0X0pXRUZYZS16UVg5WlVPbUU0cGpKSnc?oc=5","date":"2020-04-26","type":"deal","source":"CEPI","summary":"CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals' Australian Subsidiary - CEPI","headline":"CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals' Australian Subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9lUmxfX19YWVBsX1RYSHhhY1J1SDVhMm5meUtfYWduQW1VSkthSmNDLXZqd01NUzVxZEtXYWdFMV9GRXJJcHpYaTFOeUVFZC1PWkk3M2pKdFlYbE56QjBYWENPM3Y1LXZ1TXfSAXJBVV95cUxPN0d6QnhPd09ROXg5ZTdnMFM1MFpyajR2czZYSGhZcXY2M3Zuc3BvUnFQeF9iWDE2X3lNNkdXZU5BNU5YQ19Vel9wUm9VT0pLbkFuZzY4Tk9kWHVrSUNNUW0tdjNOdGdnNHo5VnhPVUgzd0E?oc=5","date":"2020-03-21","type":"pipeline","source":"Freethink","summary":"Here is every potential coronavirus treatment and vaccine - Freethink","headline":"Here is every potential coronavirus treatment and vaccine","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":2,"phase_3":2,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}